Sunitinib-Induced Hemoglobin Changes Are Related to the Dosing Schedule

A.A.M. van der Veldt, E. Boven, L. Vroling, H.J. Broxterman, A.J.M. van den Eertwegh, JB Haanen

Research output: Contribution to journal › Article › Academic › peer-review

Original language	Undefined/Unknown
Pages (from-to)	1339-1340
Journal	Journal of Clinical Oncology
Volume	27
Issue number	8
DOIs	https://doi.org/10.1200/JCO.2008.20.6151
Publication status	Published - 2009

Cite this

@article{cb3e3769153c44daa0c45b5a5026025c,

title = "Sunitinib-Induced Hemoglobin Changes Are Related to the Dosing Schedule",

author = "{van der Veldt}, A.A.M. and E. Boven and L. Vroling and H.J. Broxterman and {van den Eertwegh}, A.J.M. and JB Haanen",

year = "2009",

doi = "10.1200/JCO.2008.20.6151",

language = "Undefined/Unknown",

volume = "27",

pages = "1339--1340",

journal = "Journal of Clinical Oncology",

issn = "0732-183X",

publisher = "American Society of Clinical Oncology",

number = "8",

}

TY - JOUR

T1 - Sunitinib-Induced Hemoglobin Changes Are Related to the Dosing Schedule

AU - van der Veldt, A.A.M.

AU - Boven, E.

AU - Vroling, L.

AU - Broxterman, H.J.

AU - van den Eertwegh, A.J.M.

AU - Haanen, JB

PY - 2009

Y1 - 2009

U2 - 10.1200/JCO.2008.20.6151

DO - 10.1200/JCO.2008.20.6151

M3 - Article

C2 - 19188672

VL - 27

SP - 1339

EP - 1340

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

SN - 0732-183X

IS - 8

ER -